ReviewJournal of personalized medicine2026

Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria.

Ana Checa-Ros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.